# MaxFi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/maxfi

- Industry: Medical Devices & Equipment
- Headquarters: Missouri, US
- Website: www.maximumfidelitysurgicalsimulations.com/
- Total disclosed funding: $2.3M
- Latest round: Seed (Jul 9, 2024)
- Investors on record: 3

## About

Based in Missouri, US, Founded in the year 2016, MaxFi operates as a medical equipment manufacturer specializing in the medical simulations and reanimation of human and animal cadavers for surgical modeling. In July 2024, MaxFi raised USD 2.25 million in seed funding co-led by investors BioGenerator, Missouri Technology Corporation, and St. Louis Arch Angels.

MaxFi specializes in hyper-realistic surgical simulations through its proprietary En Vivo Perfused Cadaver (EnvivoPC®) system, supporting medical training, research, and product development. MaxFi's simulations replicate human anatomy and physiological responses hence advancing surgical education without risk to live patients. EnvivoPC® technology utilizes Simblood, a patented blood substitute, and a perfusion system to mimic heart function, blood flow dynamics, and tissue response realistically, which enables medical professionals to practice complex procedures. MaxFi also collaborates with military entities, medical schools, and biomedical device manufacturers, facilitating testing, validation of innovations, and enhanced educational outcomes.

The company plans to utilize the July 2024 funding to expand operations and its development efforts.

## Funding rounds

- Seed, Jul 9, 2024, $2.3M — BioGenerator, Missouri Technology Corporation, St. Louis Arch Angels

## Investors

- BioGenerator (https://capitalatlas.ai/funds/biogenerator) — Seed
- Missouri Technology Corporation — Seed
- St. Louis Arch Angels — Seed